INTRODUCTION

Demyelination of central nervous system (CNS) axons is
the most prominent morphological characteristic of the lesions of disorders such as multiple sclerosis, optic neur itis and acute disseminated encephalomyelitis, and it is believed that many of the symptoms associated with these disorders are directly attributable to conduction disturb ances caused by the myelin loss. This review is primarily concerned with the conduction deficits of experimentally demyelinated CNS axons, and the symptoms which may be expected to arise from these deficits. The review focusses on axons in experimental demyelinating lesions, since here the morphology of the affected axons can usually be determined with some certainty, whereas in human disease morphological changes can rarely be studied.
CONDUCTION BLOCK
The first conduction abnormality to be reliably described allergic encephalomyelitis (EAE).13 Conduction block was also described in some earlier accounts,14-16 but con fidence in these data is weakened by the uncertainty as to whether the blocked axons were truly demyelinated or were undergoing degeneration (for discussion see
McDonald and Sears 17) . Demyelination seems only to impair conduction at the site of the lesion, for conduction continues in an apparently normal manner along the mor phologically unaffected portions of the axon on either side.I.17 Conduction block is also particularly prominent when the axons are examined at body temperature and above (see Effects of Temperature below).
On theoretical grounds, the likelihood that demyel ination will result in conduction block is related to the degree of demyelination present, particularly at the para nodes. Thus conduction may be expected to continue, albeit with some reduction in velocity and security, where demyelination is restricted to loss of some but not all of the Where the demyelinated axons later acquire the ability to conduct through the lesion it is with a reduced velocity (E) and a prolonged refracto ry period of transmission (RPT), i.e. the second impulse of a closely spaced pair may fail to be tran smitted (F) and a rapid train of impulses may be trans formed to a low-frequency train due to jClilure of the lesion to transmit all the impulses (G). With repeated activation demyel inated axons can become progressil'ely less able to conduct closely spaced impulses (H), and may exhibit intermittent periods of complete conduction block (l). Transmission along demyelinated axons is markedly affected by temperature changes, such that cooling promotes successfiLl conduction (], K). Demyelinated axons can generate long trains of impulses in the absence of any deliberate stimulus (L), and can also gener ate trains of impulses in response to deformation (M). Single conducted impulses can provoke the generation of other, ectopic impulses (N). The conduction dejicits associated with demyel ination are almost entirely reversed by remyelinatioll (0, P J.
myelin lamellae (partial-thickness demyelination), or to very limited paranodal widening. IS However, where demyelination is more extensive, and certainly where it is segmental, the presence of conduction block becomes much more likely. Indeed, conduction block may be inevi table in newly segmentally demyelinated axons since there is normally only a relatively low ( < 25/)lm") sodium channel density beneath the myelin sheath (the channels expressed by myelinated axons are the subject of an excel lent recent review by Waxman and Ritchie19 (see also Ritchie and Rogart"il and Shrager21); and so, initially at least, demyelination must expose axolemma ill-equipped for cunduction of nerve impulses. However, Waxman's group have noted that conduction can occur in premyel inated optic nerve axons where the sodium channel density is also low (mly 2/) l m 2 ), 21 raising the possibility that even some freshly demyelinated axons may be able to conduct.19.2J This is an interesting possibility, but our experience is that conduction is routinely blocked in recently segmentally demyelinated axons. However, it may be significant that our experience is limited to the relatively large-diameter axons of the dorsal column, since conduction is probably favoured by a small axon diameter.2321 It is thus pos�ible that conduction may occur in, say, the recently segmentally demyelinated axons of the optic nerve, although such an event awaits description. Although newly segmentally demyelinated axons typi cally exhibit conduction block, it does not necessarily fol low that the demyelinated axolemma is inexcitable, because it may simply not be excited. In a normal myel inated axon, conduction proceeds by the excitation of each node of Ram'ier in sequence, due to the spread of local currents generated by the preceding node Wig. 2). This excitation is facilitated by the presence of the myelin sheath, which reduces the lateral flow of current by virtue of its high resistance, and facilitates the longitudinal flow of current by reducing the membrane capacitance.* The presence of the myelin sheath also focusses most of the local current specifically to the very small area of axo lemma at the node, and it is the outflow of current there which depolarises across the nodal axolemma to its tlring threshold. At this time the nodal voltage-sensitive sodium channels open, and the ensuing influx of sodium ions gen erates another local current which serves to depolarise the *The cell membrane is an insulator which separates conducting solu tions which bathe it on either side. Since the inside of the cell is negative with respect to the outside (i.e. the resting potential) there is a tendency for negative charges to line up on the inside of the membrane and for these to attract positive charges from the bathing solution to line up along the outer surface of the membrane: this arrangement of charges separated by an insulator constitutes a capacitor. Because cell mem branes are very thin the charges are physically close to each other and so they attract each other quite tightly. For the membrane to the depolarised and the capacitor discharged. energy (cun'ent) is required and the quan tity of currem is proportional to the number of charges on the mem brane. This measure i,. illlUfll. related to the area of the capacitor and to the distance separating the potentials (the smaller the distance the more charges will he attracted and the greater will be the current required to depolam,e the membrane). Inl11yelinated axons, the pre,ence of a bulky myelin sheath alnng the internode substantially reduces the internodal membrane capacitance si nce the myelin physically separates the charged particles from each other. Removal of the myelin by demyel ination results in a dramatic increase in the area of exposed axolemma, and a decrease in the di,tance of ,eparation, and this increases the next node in line.25,2(, It follows that for conduction to pro ceed across a demyelinated internode, the demyelinated axolemma must be excited by the flow of local currents generated by the action potential formed at the node pre ceding the demyelinated region. To understand how demyelination affects the flow of local currents it is help ful to consider the 'safety factor' for conduction from node to node:27 Safety factor for conduction == Current available to depolarise a node Current necessary to depolarise the node In normal axons the safety factor may be as high as 5 _ 7,25 . 27 but in demyelinated axons the safety factor is typically reduced to near unity. If the safety factor is frac tionally above I, conduction will continue (albeit with a reduced velocity, etc.) and there may be few symptoms, but if the safety factor is fractionally below I then con duction will be blocked and symptoms may be expected. Many multiple sclerosis (MS) patients appear to have large numbers of demyelinated axons with a safety factor near unity, and so even very small changes in the safety factor for conduction can have profound consequences on the severity of the neurological deficit. The reduced safety factor associated with demyelina tion arises primarily from two factors. First, the loss of the myelin means that the local currents are no longer fun nelled specifically to the small area of nodal axolemma. but rather become dissipated over a larger area of the demyelinated internode. Consequently the current avail able to depolarise any given area of membrane is reduced, and the safety factor is reduced. Second, the uncovering of a large area of axolemma by demyelination results in a K. J. SMITH large increase in the membrane capacitance of the demyel inated internode, and therefore a proportionately larger current is required to depolarise the membrane, again reducing the safety factor. In fact the geometry of the internode before the demyelinated stretch, and of the demyelinated segment itself, may mean that the safety fac tor is so low that conduction in some demyelinated axons would inevitably be blocked even if the demyelinated axo lemma were excitable.
These concepts are discussed further elsewhere, and are sometimes grouped under the concept of an 'impedence mismatch' at the site of demyelination2X-11 (see also Ras minsky ef al.12 and Smith ef al.ll). However, although con duction might inevitably be blocked in some axons, it is now known that, with time, conduction can be restored along central demyelinated axons (see next section), and thus while impedance mismatch must occur it cannot be an insuperable barrier to conduction in all axons.
However, the degree of demyelination is only one of several factors influencing the presence or absence of con duction block. Other factors are the time which has elap sed since demyelination was established, the geometry of the internode preceding the demyelinated stretch, the tem perature (see Effects of Te mperature), and properties of the previously internodal axolemma.
The interval since the demyelination was established is important since it seems that although freshly demyel inated axons routinely exhibit conduction block, the axons can adapt to the demyelinated state such that conduction may eventually be restored. Certainly. in the segmental demyelinating lesion induced by the intraspinal injection of ethidium hromide14 there is an initial period of con duction block which persists for approximately 2 weeks after segmental demyelination is established, and only then is there the appearance of appreciable numbers of demyelinated axons which conduct successfully through the lesion (P. A. Felts and K. 1. Smith, unpublished obser vations). The precise changes which occur during the 2 week period are not known, but probably include an increase in the sodium channel density along the demyel inated axolemma,nll and the development of contacts between the axons and glial cell processes.35-3X
The dimensions of the internode(s) preceding the demyelinated region are important since the safety factor for conduction will be increased if this internode is rela tively short so that the driving node is relatively close to the demyelinated axolemma:28 a short internode preceding the demyelinated region may be able to compensate for other factors which may not be optimal for conduction in a particular axon. The properties of the demyelinated axo lemma are of paramount importance since conduction cannot occur across the length of a segmentally demyel inated internode unless the axolemma actively propagates the impUlse: however. the properties of this axolemma are largely unknown. The relatively low density of sodium channels along demyelinated axolemma has already been discussed, but there are also likely to be important changes in the density, types and distribution of potassium chan-nels, electrogenic pumps and ion exchangers (reviewed in Waxman and Ritchiel,!).
RESTORATION OF CONDUCTION IN DEMYELINATED AXONS
Although McDonald and Sears found that conduction was typically blocked in axons passing through larger demyel inating lesions (> 5 mm in length), I I C.w they found that conduction continued in some axons passing through smaller lesions.ILw The conduction was not normal (see below), suggesting that the axons were among those which had been affected by the lesion. This early study examined the central demyelinating lesion induced by the injection of diphtheria toxin into the cat dorsal columns,7 9 AII but, as noted above. this lesion contained several types of demyelination. including segmental demyelination, paranodal demyelination.'J partial demyel ination (i.e. myelin thi nning(9 and. starting at 19 days. axons repaired by remyelination.' The demyelinated por tions of the axons were either completely naked, or par tially or completely ensheathed by astrocytic or Schwann cell processes.? Because the lesion contained a range of myelin abnormalities. it was not possible to determine whether conduction would occur in the segmentally demyelinated axons which are prubably of most relevance to central demyelinating diseases such as MS and optic neuritis. The more recent studies of conduction in central demyelinated aXOllS have used more homogeneous lesions, but have still not been able to determine the pres ence or absence of conduction in segmentally demyel inated axons. I O 1135 This problem has, however. recently been overcome through studies in which the conduction properties of indi vidual demyelinated central axons have been established, and then the axons labelled with horseradish peroxidase so that they could subsequently be identified beneath the light and electron microscope (P. A. Felts and K. J. Smith. unpublished observations). These studies have established that segmentally demyelinated axons can conduct, and that they have the properties expected of sLlch axons, as described below. The studies have also raised the possi bility that the patchy or continuous ensheathment of demyelinated axons by glial processes, even without remyelination, can promote the restoration of conduction, although we have found that continLlous ensheathment is not an absolute requirement for conduction. The presence of conduction in at least some demyelinated axons which remain unensheathed for portions of their length is of par ticular interest with regard to earlier immunocytochemical observations showing that it is only glial-ensheathed demyelinated central axons which exhibit high densitie� ofaxolemmal sodium channels," and to other studies showing that node-like axonal specialisations can form along demyelinated central axons. but only at sites where the axons are contacted by glial processes.153X
However, although some unensheathed demyelinated axons can conduct, it is too soon to conclude that unen sheathed demyelinated axolemma can be excitable, since at present the longitudinal extent over which demyelinated axons can be unensheathed, and yet still conduct, remains unknown. If the length is relatively short (e.g. 100 J.lm), then it may be that conduction could continue in a 'micro saltatory' manner even if the unensheathed axolemma were inexcitable, as appears to be the case in some demyelinated axons in peripheral nerve.3.l. 41 The presence of conduction in at least some continuously or patchily ensheathed demyelinated axons, and even in axons com pletely unensheathed for short (e.g. 100 J.lm) distances, is of interest with regard to a detailed ultrastructural study which has shown the presence of these different types of demyelinated axon in MS lesions:41 the fact that con duction can occur in each type of axon can explain the sev eral reports of clinically 'silent' demyelinating lesions in pathways where conduction block would be expected to cause symptoms.2..lH1 The restoration of conduction to demyelinated axons is likely to be an important cause of the remissions often seen in central demyelinating dis eases (see also Conduction in Remyelinated Central Axons below).
Since a major cause of the symptoms in diseases such as MS and optic neuritis is conduction block in central demyelinated axons. it follows that pharmacological agents which can restore conduction may be effective in the symptomatic therapy of such diseases. Potential strat egies for the use of such agents have been discussed45-51 (and Blakemore, this issues I,,) and in clinical trials some agents have been demonstrated to be effective in reducing symptOlm 4752-5.1 (see also discussion under Effects of Te mperature and Transmission of Impulse Tr ains below).
CONDUCTION SLOWING
It is clear that when conduction occurs in central demyel inated axons it is with a slow velocity, and so the latency of conduction is prolonged (Fig. I E) . The slowing of con duction is restricted to the demyelinated portion of the tibre. 17 The conduction velocity specifically along the demyelinated segment has not been determined in central demyelinated axons as precisely as in their peripheral counterparts, but the velocity is likely to be no more than \--3 m/s (P. A. Felts and K. 1. Smith, unpublished observations).
Conduction slowing can account for certain subtle signs and symptoms in central demyelinating diseases, such as the Pulfrich phenomenon noticed by some patients with unilateral optic neuritis 5 ' (one patient with optic neuritis reported that oncoming traffic appeared to travel in a curve towards him; personal communication), and it may also interfere with vibration sensation, which depends upon the arrival in the brain of synchronised bursts of activity along different axons.i.S6 A generalised, similar delay in latency across many axons probably does not impair func tion significantly. since such delays must occur upon cool ing of the limbs on a cold day and yet casual observation indicates that satisfactory function is preserved. MS patients also often fail to perceive any deficit in vision even when there are gross delays in' the visual evoked potentia!.5) Fig. 3 . Records of activity in a single unit isolated from an intercostal nerve caudal to an experimental demYelinating lesion (hatched area) in the cat dorsal column. The lower record shows that when the conduction pathway excluded the lesion the unit was able fa ithfully to fo llow supramax imal stimuli applied at 1000 Hz, but when the lesion was included in the conduction pathway (upper record) the unit was only able to fo llow stimuli at 410 Hz: indeed, after the first few responses the unit was able to conduct only the impulses arising fr om alternate stimuli. 1n this figure the action potentials are the shorter, continuous lines immediately fo llowing each stimulus artefact, which appears as a dotted line. (Reprinted fr om McDonald and Sears i7 with permission).
EVOKED POTENTIALS
Slowed conduction in demyelinated central axons, poss ibly coupled with a reduction in the total number of axons conducting, leads to significant delays and other alter ations in the visual, somatosensory and brainstem audi tory evoked potentials.4.57-66 The changes in the form of the evoked potential, particularly the increase in latency, have proved to be of significant value in the diagnosis of demyelinating disorders such as multiple sclerosis.4.67.6 8 McDonald69 has estimated that the reduced conduction velocity associated with demyelination provides a suf ficient cause of the prominent delays in visual evoked potentials, and this view is supported by the observation that in MS the delay in the visual evoked potential persists after the recovery of vision, in combination with persistent demyelination of the optic nerve.57
REFRACTORY PERIOD OF TRANSMISSION
Recordings from single fibres passing through central demyelinating lesions have shown that some axons, pre sumed demyelinated, are less able than others to conduct closely spaced pairs of impulses (Fig. ID) . 17 McDonald and Sears introduced the term 'the refractory period of transmission (RPT)' to describe this property, and the RPT is defined as the maximum interval between two supra maximal stimuli at which the action potential arising from the second stimulus just fails to be propagated through the lesion. Thus the RPT is distinct from the more commonly described 'refractory period', which measures properties of the axon at the stimulating cathode. 70 In demyelinated axons the RPT is prolonged partly as a consequence of the K. J. SMITH slowed conduction through the lesion: the reduced con duction velocity means that the first impulse lingers at the demyelinated site, preventing transmission of a second impulse following closely behind. McDonald and Sears17 found the normal range of RPT in the cat dorsal columns to be 0.4-1.1 ms (mean 0.86 ms), but this was prolonged to 1.2---4 .2 ms in most axons passing through the site of a demyelinating lesion. More recent studies have confirmed that the RPT is prolonged in axons proven upon ultrastruc tural examination to be segmentally demyelinated, with the RPT ranging from 0.55 to 1.4 ms (mean 0.83 ms, n = 21) along the unaffected part of the central axons, to 1.0-27.0 ms (mean 3.76 ms) in the same axons when the lesion was included in the conduction pathway (P. A. Felts and K. J. Smith, unpublished observations). The factors underlying the increase in RPT have recently been studied using computer simulations of conduction along partially demyelinated axons.71
TRANSMISSION OF IMPULSE TRAINS
The prolonged RPT of demyelinated axons inevitably lim its the maximum frequency at which the axons can trans mit trains of impulses (Fig. IF, G) , but this deficit is only one of three deficits expressed by demyelinated axons with respect to the conduction of impulse trains. Demyel inated axons can also accumulate refractoriness with con tinued activation such that the maximum frequency which can be transmitted is progressively reduced (Fig. IH) .I7·72 For example, an axon may be able to conduct two or three impulses at 410Hz, but then only to conduct impulses in response to alternate stimuli (Fig. 3) . 17 In other axons McDonald and Sears found conduction deficits revealed only at 70 Hz,73 a frequency well within the range at which axons are normally required to fire. The accumulation of refractoriness may well contribute to the increasing weak ness and fatigue observed upon sustained muscular con traction in MS patients,' and possibly to the 'fading out' of vision reported by some MS patients if the gaze is fixated on a point for several seconds. 74 The third deficit expressed by demyelinated central axons during the conduction of impulse trains is the appearance of intermittent periods of complete con duction block (Fig. I I) . These periods develop after sev- (Fig. 4 ; R. Kapoor, P. A. Felts and K. J. Smith. unpublished observations). In peripheral demyelinated axons the periods of conduction block have been shown to be due to membrane hyperpolarisation resulting from activity of the Na+/K+ ATPase,75.76 and this finding has now also been extended to central demyelinated axons (Fig. 5 ; R. Kapoor, P. A. Felts and K. J. Smith. unpublished obser vations). During the period of 200 Hz stimulation it is supposed that a sufficient accumulation of potassium ions occurs outside the axon, and of sodium ions inside, that the activity of the Na+/K+-ATPase is stimulated: this pump is electrogenic, contributing to membrane hyperpolarisa tion. Bostock and Grafe76 have also discussed other mech anisms which may contribute to deficits in the transmission of high-frequency impulse trains, including the accumulation of sodium ions within the axon at the driving node,77 and depolarisation of the demyelinated axons due to increases in extracellular potassium.7X
If the intermittent conduction block is due to activity of the Na+/K+-ATPase, it may be predicted that inhibitors of this pump, such as ouabain, may temporarily alleviate the conduction block. However, we have found this prediction difficult to prove in I'itm, perhaps due to the relative inaccessibility of the central lesion to this particular drug (R. Kapoor, P. A. Felts and K. J. Smith, unpublished obser vations). However, such drugs have been reported to improve conduction in peripheral79 and centralXO demyel inated axons, and to improve symptoms in three of seven patients with probable or definite MS. 47 The reduced ability of central demyelinated axons to conduct trains of impulses may contribute to the reduced fl icker fusion frequency observed in patients,SI and which is also apparent when monitoring the visual evoked poten tial:s2, 8 3 similar changes occur in the somatosensory evo ked potential. 8 4
EFFECTS OF TEMPERATURE
It is well known to many MS patients that changes in body temperature can affect symptoms, and as early as 1890 Uhthoff. an ophthalmologist, described deterioration of vision upon exercise. 8 5 Indeed, the effects of temperature changes on the symptoms and signs of MS are well docu mented (Fig. I J, K) 8 6-93 and there have been several accounts of the extreme sensitivity of symptoms to changes in body temperature (reviewed by Matthews94) such as improvements in vision upon drinking a glass of cold water,95 or the deleterious effects of sunbathing,96 a hot shower,,!7 hot drink, or the use of a hair dryer;9 8 changes due to circadian temperature variations have also been reported.99IO() Indeed, the deterioration in symptoms can be so rapid and severe upon warming that a patient may require support to prevent drowning in a hot bath, 101 and, indeed, a fatal case of scalding in a hot bath has been reported.'!7 The effects of warming are relatively specific to central demyelinating diseases, and diagnostic use has been made of the phenomenon, the 'hot bath test'
.
102-104
The temperature-induced changes in symptoms are typi cally reversible (but see also Berger and Sheremata96 , 10 5
and DavisluO). The effects of temperature on the symptomatology of MS predict that temperature increases will contribute to conduction block in central demyelinated axons, and vice versa, and this view is supported by computer simu lations 1 8 ,4 6 and experimental observations in peripheral demyelinated axons.49,50.l07-11U The effects of temperature on central demyelinated axons have now been examined directly, using the demyelinating lesion induced by the intraspinal injection of ethidium bromide ( 
ECTOPIC ACTIVITY
The presence of ectopic discharges is well documented in peripheral demyelinated,123-125 chronically inj ured I '6 and amyelinatedl27-129 axons, but studies in central demyel inated axons are few.
Smith and McDonaldl30131 reported the presence of ongoing discharges in axons passing through a demyel inating lesion caused by the intraspinal injection of Iyso phosphatidyl choline, and showed that the discharges arose ectopically at the lesion, propagating in both direc tions from it. The discharges were either of evenly spaced impulses, or of bursts of impulses (Fig. I L) . and they con tinued for long periods (hours) in the absence of any delib erate stimulation. These authors argued that since the discharges occurred for prolonged periods across many sensory axons, the discharges provided a sufficient explanation for many of the 'positive' symptoms com monly experienced by patients with central demyelinating disorders, such as tingling paraesthesiae.
The demyelinated axons were also extremely mech anosensitive (Fig. 1M) , such that the firing rate of dis charging units was markedly increased upon even small deformations of the lesion using an eyelash. and such mechanical stimulation also induced activity in many axons which were otherwise electrically �ilent. This mechanosensitivity of the axons has been advanced as an explanation for the phenomenon of Lhermitte' s symp tom,m,133 namely a radiating pins and needles sensation upon stretching the cervical spinal cord, for example upon K. J, SMITH bending to tie a shoe lace: the cervical cord is a common Potential mechanism(s) underlying the paroxysmal symptoms of MS"-l have heen discussed by Rasminsk/2) and may involve the ephaptic excitation of myelinated axons which happen to be located adjacent to demyel inated axons. It is also possible that if adjacent demyel inated axons are not separated by intervening glial processes they may be able to excite each other, resulting in a synchronous, lateral spread of excitation across many axons,1 3 9 although this remains unproven.
TOXIC OR 'NEUROELECTRIC BLOCKING' FACTORS
A research area of great potential importance to MS con cerns the putative existence of circulating factors which can modulate symptoms in the disease. The evidence in favour of such factors is unfortunately conflicting and inconclusive, but it seems appropriate to include this research area in this review which attempts. in part, to ill uminate the genesis of symptoms in MS.
The research is founded in the belief by some investi gators that the production of symptoms in MS cannot be completely explained by demyelination.I�II.I�1 (see also RoseI42). This view was encouraged by the observation that relapses and remissions can occur quite rapidly in the disease, perhaps too rapidly to be readily explained by demyelination and remyelination alone: 1� 1 indeed. at the time, remyelination was thought to be very limited or absent in this disease. The suspicion that MS symptoms were not necessarily due to demyelination was strength ened by several reports which described the presence of prominent symptoms in animals with EAE. although little or no demyelination was detected to account for them.144 151 These findings indicated that unknown factor(s) were contributing to the symptoms of MS and EAE by blocking conduction: these factors were called neuroelectric blocking factors.
As time has progressed, however, the rationale pre dicting the presence of neuroelectric blocking factors has been largely undermined, for we now know that demyel ination can occur quite rapidly in both central and periph eral nervous systems,
iii. I 1 . 15 :' and careful histological study of animals with EAE has revealed ample demyelination to account for the deficits observed. 1 5 . 1 -1 5 6 Furthermore. it is now clear that remyelination can be quite complete in both the early MS lesion,157 15x and in EAE.154 and where it occurs it presumably contributes to remissions." However, although the reasons for predicting the presence of neu roelectric blocking factors may have diminished. there are several reports that such factors are present in demyelinat ing disorders. The first, relatively small study indicating the possible presence of such factors indicated that. within minutes of application, sera obtained from animals with EAE and from MS patients during acute exacerbation partially blocked reflex activity evoked in cultured mouse brain and spinal cord.159 The blocking activity was described as reversible and dependent upon complement. although few controls were examined. The findings were sup portedI4116o.If>1 by similar studies examining isolated frog spinal cord, which, in addition. indicated that the blocking activity was specific to MS sera and was not found in either normal human sera or in sera from patients with sev eral other neurological disorders. These findings were confirmed by Lumsden et al.1lo:' 163 using guinea pig tissue and again by Schauf et al.IM using an isolated frog spinal cord preparation. The blocking activity was later found to be correlated with the occurrence of clinical signs and symptoms in MS.1 65 .1 66
However, Seil's group, examining reflex activity evo ked in mouse cerebral neocortex, found neuroelectric blocking activity not only in sera from patients with MS 167 and from rats with EAEIloR (irrespective of the clinical state)1lo9 but also in sera from control rats and from normal human volunteers. Blocking activity was also found in normal rat and human sera by another group. 170 Seil et al. therefore concluded that the neuroelectric blocking activ ity was a non-specific property of many human and animal sera, although these authors pointed out that the blocking activity may still act relatively specifically since it is only when the blood-brain barrier is compromised (as it is in MS) that serum factors may be expected to gain access to the CNS. 167 It should be noted that further studies by other groups failed to detect blocking activity in normal sera, or sera from patients suffering from Guillain-Barre syndrome (unpubl ished observations cited in Schauf and Davis 143) or strokesllo5 (but see Schmutz et al.171), although blocking activity was found in sera from patients with amyotrophic lateral sclerosis 172 and certain other diseases. 171 The reasons for the conflicting findings remain unexplained, but have been attributed partly to differences in the record ing techniques and in the interpretation of the data, and to differences in the type of explant examined. 17 3 . 1 74 The identity of the blocking factor(s) remains uncertain, although most studies report a suspected role for anti neural antibodies, due partly to the apparent dependence of the blocking activity on complement, and partly to the localisation of the blocking activity in the IgG-containing fraction of serum.IHI66.171J Furthermore. plasma exchange in MS patients, which removes factors such as blood borne antibodies and immune complexes, also reduces or eliminates serum neuroelectric blocking acti vity.143, 175 If antibodies are involved, then it is likely that they act by means other than demyelination 17 6. 177 since their action is both rapid (within minutes) and reversible. It seems likely that factors other than antibodies are also involved, since Sei I' s studies indicated the presence of several serum neu roelectric blocking factors, not all of which were anti bodies and only some of which were complement dependent. 167 With more recent knowledge it seems possible that some of the blocking activity may have been due to factors associated with inflammation,66.17x since several cytokines have now been reported to affect ionic currents in neural tissues.l7Y I X6 Whether cytokines are involved in the modu lation of either synaptic transmission or of conduction in demyelinated axons remains uncertain, although it is an interesting possibility which forms an exciting and poten tial ly rewarding area for current and future research.
Notwithstanding the above, the relationship between neuroelectric blocking factors and the symptomatology of demyelinating disease remains obscure, as does the poten tial mechanism of their action in the disease. It is note-worthy that neuroelectric blocking activity is assayed by detecting the ability of sera to depress the amplitude of reflex acti vity evoked by the electrical stimulation of CNS tissue. Thus the sera are assayed mainly for their actions on synaptic transmission, and not for their action on demyelinated axons. This distinction is important but easily overlooked since the relevant literature is concerned with the role of blocking factors in the -;ymptomatology of demyelinating disease. and some author� suggest that the factors might be expected to cause conduction block in demyelinated axons due to their low safety factor for con duction.16),166 Tn fact, when sera with potent neuroelectric blocking activity were eventually tested for their effect on myelinated and demyelinated axons. no detectable effect was found.143 The sera did. however, inhibit transmitter release at the frog neuromuscular junction,I.1-' comistent with the blocking effect detected on reflex activity in the CNS.
Therefore. if neuroelectric blocking factors do affect symptoms in MS, it is likely that they do so by depressing synaptic transmission, rather than by promoting con duction block in demyelinated axons. However. whether the factors have any role in the symptomatology of MS is uncertain, since cerebrospinal fluid wa" found to be generally free of blocking activity, even in those patients in whom corresponding serum samples had potent neu roelectric blocking actjvity. I�3 In summary. v,'hile it seems likely that factors other than demyelination may affect symptoms in MS, especially given the low safety factor for conduction in many demyelinated axons. the role of serum 'neuroelectric blocking factors' remains unclear.
CONDUCTION IN REMYELINATED CENTRAL AXONS
There are two reasons for sllspecting that the repair of demyelination by remyelination may not necessarily be accompanied by the restoration of cLlnduction to the repaired axons. First, remyelinated internodes are �horter than the normal internodes they replace, 1 87 1 8K and so the new nodes of Ran vier are formed around axolemma which was previously covered by myelin and which therefore lacks the high concentration of sodium channels normally present at the node. I'! Second, remyelinated internodes are noticeably thinner than normaL 1 8 7.1 88 which may be expected to increase membrane capacitance and thereby reduce the safety factor (although computer simulations suggest that even a very thin myelin sheath may be com patible with conduction).IS,l 8 9 The diphtheria toxin lesion, which revealed many of the fundamental conduction properties of central demyeli nated axons, does not undergo extensive remyelination7 and determination of the conduction properties of central remyelinated axons awaited development of the central LPC lesion. 190 In this lesion all the demyelinated axons are eventually repaired by remyelination, effected largely by oligodendrocytes although some axons are repaired by Schwann cells which invade the central nervous system. Serial electrophysiological study of the lesion established K. 1. SMITH that remyelination was accompanied by the restoration of conduction to most, if not all, of the remyelinated axons,I II. 11 and that the repaired axons conducted securely, with refractory periods of transmission indistinguishable from normal : the conduction velocity was also improved such that the latency of the response was returned to within normal limits. A later. similar, study established that the repair of central axons by Schwann cells (the per ipheral myelinating cell ) was similarly effective in restor ing secure conduction,12 raising the possibility that the transplantation of Schwann cells to central lesions may be effective in reversing symptoms. Such an approach would result in the formation on the central axons of peripheral myelin which. by analogy with the sparing of myelin in the peripheral nervous system in MS. may be resistant to the disease process.
Rell lyelination is believed to contribute to recovery from acute EAE, 155 and since it is now known that remyel ination can be quite widespread in some lesions in MS, 1571Y I192 it is probable that remyelination contributes to the remissions commonly seen in this disease.6
SOME AVENUES FOR THE SYMPTOMATIC THERAPY OF CENTRAL DEMYELINATING DISEASE
It is now proven that central demyelinated axons can con duct. but it is also clear that frequently they fail to conduct in central demyelinating diseases. Since the fundamental wiring of the eNS is largely preserved in such diseases, it is reasonable to believe that an effective symptomatic therapy may be built around the reversal of this persistent conduction block. Certainly this belief is encouraged by the common observation that symptoms can be substan tially improved by the restoration of conduction resulting from a reduction in body temperature (see above). There fore, one promising avenue for research concerns the iden tification of safe drugs which mimic temperature reductions in that they restore conduction by prolonging action potential duration. A problem with some of the agents examined so far (e.g. scorpion toxin, 4-AP) is the possibility of convulsant side effects resulting from the increased quantities of transmitter released at central syn apses in response to the prolonged action potentials. How ever, it is conceivable that agents may be found which bind to channels (yet to be identified) which are specific to regions of demyelinated central axolemma, and such agents could be relatively fr ee from dangerous side effects. Certainly. the realisation that there are a multi plicity of channels and receptors (particularly potassium channels but including ATPases. ion exchangers and receptors for neurotransmitters) along normal and demyelinated axons gives realistic hope that a pharmac ological therapy targeted �pecifically at demyelinated lesions may be achieved. As mentioned above, one potassium channel blocking agent. 4-AP, is partially effective in the symptomatic ther apy of MS. However, there is also evidence that at the con centrations achievable in patients 4-AP may exert its beneficial effects not by the restoration of conduction to blocked axons, as is commonly supposed, but rather by the potentiation of synaptic transmission (P. A. Felts and K. J. Smith, unpublished observations). It is easy to imagine that in a pathway where conduction in many axons is blocked, the potentiation of synaptic transmission in the few remaining axons may result in a partial remission of symptoms. This consideration is exciting in that it raises the possibility of a new avenue for the symptomatic ther apy of MS, namely one directed at synaptic transmission. This approach would circumvent the problem of persistent conduction block in demyelinated axons (P . A. Felts and K. J. Smith, in preparation).
The potential role that oedema, inflammation and inflammatory mediators may play in the promotion of conduction block remains uncertain and largely unex plored, but it is likely that research into these arcas will be rewarded with new insights for the symptomatic therapy of central demyelinating disease.
With regard to 'positive' symptoms (e.g. paraesthesiae and phosphenes), it is likely that potential avenues for the elimination of ectopic impulses may arise from a better understanding of the mechanism( s) underlying their gen eration. Recent evidence 136.137 implicates a role for dis ordered potassium homeostasis which may be overcome by manipUlating the glial environment of the demyel inated axons.
It is known that remyelination is effective in restoring secure conduction to demyelinated axons. J() 12 but that remyelination is typically limited in extent in MS. Now that it is possible to use MRI safely to identify the locations of demyelinating lesions during life, it may be possible to transplant cultured glial or Schwann cells directly into symptomatic lesions (e.g. in the optic nerve) to effect both a morphological and functional repair (Tar gett and Blakemore, this issue 51 a) . Alternatively, it may be possible to administer glial growth and/or trophic fac tors to promote the natural tendency of central demyel inating lesions to undergo repair by endogenous glial cells. The apparent ability of glial cells to influence the assortment of voltage-sensitive channels along demyel inated axolemma ' s offers another avenue by which glial transplantation may promote remission from symptoms. Other potential avenues for the therapy of central demyel inating diseases have recently been reviewed.19 511 9 l
